Search Results - "Hullegie, S.J."

Safety of rilpivirine and boceprevir co-administration in HIV-infected patients treated for acute hepatitis C virus infection by Hullegie, S.J., de Winter, B.C.M., Posthouwer, D., Koopmans, P.P., Claassen, M.A.A., Burger, D.M., Rijnders, B.J.A.

Get full text

Current knowledge and future perspectives on acute hepatitis C infection by Hullegie, S.J., Arends, J.E., Rijnders, B.J.A., Irving, W.L., Salmon, D., Prins, M., Wensing, A.M., Klenerman, P., Leblebicioglu, H., Boesecke, C., Rockstroh, J.K., Hoepelman, A.I.M.

“…Acute hepatitis C virus (HCV) infections are frequently seen worldwide in certain risk groups, with an annual incidence rate varying between 0.08% and 66%…”
Get full text

Use of whole genome sequencing in the Dutch Acute HCV in HIV study: focus on transmitted antiviral resistance by Christiansen, M.T., Hullegie, S.J., Schutten, M., Einer-Jensen, K., Tutill, H.J., Breuer, J., Rijnders, B.J.A.

“…Within HIV-positive men having sex with men, the epidemic of hepatitis C virus (HCV) is ongoing. Transmission of resistant variants of HCV after failure of…”
Get full text

Acute hepatitis C in the Netherlands: characteristics of the epidemic in 2014 by Hullegie, S.J., van den Berk, G.E.L., Leyten, E.M.S., Arends, J.E., Lauw, F.N., van der Meer, J.T.M., Posthouwer, D., van Eeden, A., Koopmans, P.P., Richter, C., van Kasteren, M.E.E., Kroon, F.P., Bierman, W.F.W., Groeneveld, P.H.P., Lettinga, K.D., Soetekouw, R., Peters, E.J.G., Verhagen, D.W.M., van Sighem, A.I., Claassen, M.A.A., Rijnders, B.J.A.

“…Within the Dutch Acute HCV in HIV Study, a surveillance system was initiated to estimate the incidence of hepatitis C virus (HCV) infections in 2014. Following…”
Get full text